DK449988D0 - Farmaceutisk praeparat med dobbeltstrenget rna - Google Patents

Farmaceutisk praeparat med dobbeltstrenget rna

Info

Publication number
DK449988D0
DK449988D0 DK449988A DK449988A DK449988D0 DK 449988 D0 DK449988 D0 DK 449988D0 DK 449988 A DK449988 A DK 449988A DK 449988 A DK449988 A DK 449988A DK 449988 D0 DK449988 D0 DK 449988D0
Authority
DK
Denmark
Prior art keywords
double
pharmaceutical preparation
stranded rna
ternary complexes
surfactant
Prior art date
Application number
DK449988A
Other languages
English (en)
Other versions
DK449988A (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK449988D0 publication Critical patent/DK449988D0/da
Publication of DK449988A publication Critical patent/DK449988A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Holo Graphy (AREA)
  • Details Or Accessories Of Spraying Plant Or Apparatus (AREA)
  • Credit Cards Or The Like (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK449988A 1987-08-12 1988-08-11 Farmaceutisk praeparat med dobbeltstrenget rna DK449988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422687A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
DK449988D0 true DK449988D0 (da) 1988-08-11
DK449988A DK449988A (da) 1989-02-13

Family

ID=22183613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK449988A DK449988A (da) 1987-08-12 1988-08-11 Farmaceutisk praeparat med dobbeltstrenget rna

Country Status (20)

Country Link
EP (1) EP0303516B1 (da)
JP (1) JP2714021B2 (da)
KR (1) KR970007904B1 (da)
CN (1) CN1031325A (da)
AT (1) ATE108066T1 (da)
AU (3) AU2053688A (da)
CA (1) CA1327001C (da)
DE (1) DE3850535T2 (da)
DK (1) DK449988A (da)
FI (1) FI883734A (da)
HU (1) HU209749B (da)
IE (1) IE66830B1 (da)
IL (1) IL87415A (da)
MX (1) MX12643A (da)
NO (1) NO883564L (da)
NZ (1) NZ225755A (da)
PH (1) PH31174A (da)
PT (1) PT88248B (da)
RU (1) RU2061470C1 (da)
ZA (1) ZA885874B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
EP0695186A1 (en) * 1993-04-28 1996-02-07 Ribozyme Pharmaceuticals, Inc. Ocular delivery of nucleic acid
JP2690276B2 (ja) * 1995-01-10 1997-12-10 科学技術振興事業団 静電結合型高分子ミセル薬物担体とその薬剤
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
GB2353282C (en) 1998-03-20 2013-02-27 State Queensland Primary Ind Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
NZ553687A (en) 2000-03-30 2010-03-26 Whitehead Biomedical Inst RNA sequence-specific mediators of RNA interference
SI1407044T2 (en) 2000-12-01 2018-03-30 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Small RNA molecules that mediate RNA interference
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
JP2005324511A (ja) * 2004-05-17 2005-11-24 Kawamura Sangyo Kk 積層体及びその製造方法
UA93354C2 (ru) * 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
EP2351577A1 (en) * 2004-12-29 2011-08-03 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
FR2885808B1 (fr) * 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
US9139850B2 (en) 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
WO2007102608A1 (ja) * 2006-03-06 2007-09-13 Nanocarrier Co., Ltd. 疎水性化合物の安定化剤
EP2413961B1 (en) * 2009-03-31 2016-08-17 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3582468A (en) * 1968-09-27 1971-06-01 Merck & Co Inc Recovery of double-stranded ribonucleic acid
BE793157A (fr) * 1971-12-21 1973-06-21 Beecham Group Ltd Substance antivirale
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4415548A (en) * 1980-02-12 1983-11-15 Schmid Laboratories, Inc. Spermicidally lubricated prophylactics and method for making same
JPS57209050A (en) * 1981-06-19 1982-12-22 Jekusu Kk Condome
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
JPS59124514U (ja) * 1983-02-10 1984-08-22 不二ラテックス株式会社 避妊効果を確実に向上させたコンド−ム
FR2556727B1 (fr) * 1983-12-19 1990-01-19 Biostabilex Labo Pharma Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
AU1736592A (en) 1992-07-30
PH31174A (en) 1998-03-20
ATE108066T1 (de) 1994-07-15
KR890003387A (ko) 1989-04-14
NO883564L (no) 1989-02-13
NO883564D0 (no) 1988-08-11
FI883734A (fi) 1989-02-13
MX12643A (es) 1993-09-01
FI883734A0 (fi) 1988-08-11
RU2061470C1 (ru) 1996-06-10
HUT47855A (en) 1989-04-28
HU209749B (en) 1994-10-28
NZ225755A (en) 1990-03-27
DE3850535T2 (de) 1995-01-12
KR970007904B1 (ko) 1997-05-17
IE66830B1 (en) 1996-02-07
PT88248A (pt) 1989-06-30
IL87415A (en) 1993-05-13
PT88248B (pt) 1995-03-01
IE882398L (en) 1989-02-12
CA1327001C (en) 1994-02-15
DK449988A (da) 1989-02-13
JP2714021B2 (ja) 1998-02-16
EP0303516A2 (en) 1989-02-15
EP0303516A3 (en) 1989-12-06
AU2053688A (en) 1989-04-20
EP0303516B1 (en) 1994-07-06
IL87415A0 (en) 1989-01-31
ZA885874B (en) 1989-04-26
CN1031325A (zh) 1989-03-01
AU1001395A (en) 1995-03-09
JPH01139531A (ja) 1989-06-01
DE3850535D1 (de) 1994-08-11

Similar Documents

Publication Publication Date Title
DK449988D0 (da) Farmaceutisk praeparat med dobbeltstrenget rna
ES2165269A1 (es) Derivados de alfa-cetoamidas.
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
CA2068943A1 (en) 1,3-oxathiolanes useful in the treatment of hepatitis
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
EP1340744A3 (en) Hiv protease inhibitors
ATE249219T1 (de) Antivirale verbindungen
DK0661992T3 (da) Farmaceutiske sammensætninger med interleukin-1 inhibitorer
GR3014998T3 (en) Sulfonic stilbene derivatives in the treatment of viral diseases.
RU92016277A (ru) Микробиоциды
MC1791A1 (fr) Association antivirale
DK79784D0 (da) Anti-herpesforbindelser
MXPA02011969A (es) Metodos para el tratamiento de padecimientos virales con il-18 y combinaciones de il-18.
ATE89569T1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
AU2396900A (en) Treatment and prevention of hiv and other viral infections
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
MD421C2 (ro) Derivaţi ai aminoacizilor şi sărurile acido-aditive ale acestora

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment